SAN JOSE, CA, Feb. 27, 2020– MGI, part of the global genomics leader BGI Group, announced an agreement with SOPHiA GENETICS to provide MGI’s customers access to the SOPHiA Platform for data analysis and interpretation. By combining MGI’s DNBSEQ™ sequencing technology with SOPHiA’s Platform, MGI provides an effective solution for clinical researchers and further drives adoption of MGI’s genetic sequencers. Under the terms of the non-exclusive agreement, MGI’s customers will have the ...

On March 4, 2020, the CCTV13 news channel's "Special Report on Epidemic Situation" reported in detail of Zhejiang Provincial People's Hospital for remote inspection and remote consultation through MGI's intelligent ultrasonic remote robot, achieving the two places' linkage and treating patients. According to news reports, on March 2, in the intensive care unit of Wuhan University Zhongnan Hospital, which was hosted by the People's Hospital of Zhejiang Province, a newly diagnosed patient with ...

To handle the epidemic situation, the new type of coronavirus nucleic acid test is the key, which is an important basis for clinical diagnosis and patient rehabilitation and discharge, and also a basis for judging the removal of suspected cases and the release of contacts.The research and development and production of equipment have received great attention from leaders of the Party Central Committee, the State Council and governments at all levels. On February 28, Li Keqiang, member of t...

MARCO ISLAND, FL, February 26, 2020 – Early users presented data on MGI’s new CoolMPS™ antibody-based sequencing chemistry and on the company’s DNBSEQ™ platform this week at the Advances in Genome Biology and Technology (AGBT) annual conference. MGI recently announced commercial availability of its sequencing instruments and reagent kits in the United States based on the innovative CoolMPS™sequencing chemistry, starting in April of this year. At AGBT, MGI hosted technology talks with...

In response to the development of new coronavirus epidemics, improving sample detection throughput is a top priority. Nucleic acid extraction through an automated sample preparation system can optimize key speed-limiting steps in the detection process and increase the speed of large-scale sample detection as a whole. At present, two automated sample preparation systems: MGISP-960 and MGISP-100 have obtained NMPA certification. Among them, the throughput of MGISP-960 has been upgraded from...

MGI responded today to a motion filed by Illumina in the US District Court for the Northern District of California for a preliminary injunction to try to prevent MGI from distributing sequencers in the US, saying Illumina’s motion is without merit. Illumina’s motion for a preliminary injunction is not directed to MGI’s novel CoolMPS reagent kits or the use of MGI’s sequencers with the CoolMPS reagent kits. Rather, Illumina’s motion is directed at preventing even minimal use of MGI...